Jackson Vision | |
817 W Ganson St, Jackson, MI 49202-4255 | |
(517) 782-4300 | |
(517) 782-4708 |
Full Name | Jackson Vision |
---|---|
Type | Facility |
Speciality | Optometrist |
Location | 817 W Ganson St, Jackson, Michigan |
Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1043349467 | NPI | - | NPPES |
900C810850 | Other | MI | BCBS |
22-20042 | Other | MI | PHP # |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152W00000X | Optometrist | 4901003631 (Michigan) | Primary |
Provider Name | Steven G Johnson |
---|---|
Provider Type | Practitioner - Optometry |
Provider Identifiers | NPI Number: 1366413072 PECOS PAC ID: 8022005107 Enrollment ID: I20040504000857 |
News Archive
For years brain scientists have puzzled over the shadowy role played by the molecule putrescine, which always seems to be present in the brain following an epileptic seizure, but without a clear indication whether it was there to exacerbate brain damage that follows a seizure or protect the brain from it. A new Brown University study unmasks the molecule as squarely on the side of good: It seems to protect against seizures hours later.
Data from the Columbia University Department of Urology demonstrates that Zyflamend, a unique herbal extract preparation, suppresses the growth of prostate cancer cells and induces prostate cancer cells to self-destruct via a process called "apoptosis."
A research consortium made up of the Virgen del Rocio hospital in Seville, Sant Joan de Deu and the Bellvitge Biomedical Research Institute in Barcelona, has found a new therapeutic alternative for children who suffer from a malignant pediatric tumor bone and soft tissue called Ewing's sarcoma.
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces today that it has entered into a research-based collaboration with Santaris Pharma A/S, a leading player in RNA-based therapeutics, to develop its proprietary Locked Nucleic Acid (LNA) technology in a range of rare diseases, thereby enabling Shire to build on its already strong competitive position for its Human Genetic Therapies (HGT) business.
Dianne Stewart, former head of Board and Donor relations at the Global Fund to Fight AIDS, Tuberculosis and Malaria, has joined the International AIDS Vaccine Initiative (IAVI) as Vice President of Resource Development. In her role at IAVI, Ms. Stewart will provide leadership for the organization's fundraising strategy focused on both the public and private sectors.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Jackson Vision 817 W Ganson St, Jackson, MI 49202-4255 Ph: (517) 782-4300 | Jackson Vision 817 W Ganson St, Jackson, MI 49202-4255 Ph: (517) 782-4300 |
News Archive
For years brain scientists have puzzled over the shadowy role played by the molecule putrescine, which always seems to be present in the brain following an epileptic seizure, but without a clear indication whether it was there to exacerbate brain damage that follows a seizure or protect the brain from it. A new Brown University study unmasks the molecule as squarely on the side of good: It seems to protect against seizures hours later.
Data from the Columbia University Department of Urology demonstrates that Zyflamend, a unique herbal extract preparation, suppresses the growth of prostate cancer cells and induces prostate cancer cells to self-destruct via a process called "apoptosis."
A research consortium made up of the Virgen del Rocio hospital in Seville, Sant Joan de Deu and the Bellvitge Biomedical Research Institute in Barcelona, has found a new therapeutic alternative for children who suffer from a malignant pediatric tumor bone and soft tissue called Ewing's sarcoma.
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces today that it has entered into a research-based collaboration with Santaris Pharma A/S, a leading player in RNA-based therapeutics, to develop its proprietary Locked Nucleic Acid (LNA) technology in a range of rare diseases, thereby enabling Shire to build on its already strong competitive position for its Human Genetic Therapies (HGT) business.
Dianne Stewart, former head of Board and Donor relations at the Global Fund to Fight AIDS, Tuberculosis and Malaria, has joined the International AIDS Vaccine Initiative (IAVI) as Vice President of Resource Development. In her role at IAVI, Ms. Stewart will provide leadership for the organization's fundraising strategy focused on both the public and private sectors.
› Verified 8 days ago
John P Veith, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1116 W Ganson St, Jackson, MI 49202 Phone: 800-551-7347 | |
Schaff Vision Care, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 2700 Wildwood Ave, Jackson, MI 49202 Phone: 517-789-8119 Fax: 517-789-6276 | |
Dr. Heidi Lynn Schefferly, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 306 W Washington Ave, Suite 104, Jackson, MI 49201 Phone: 517-783-6928 | |
Dr. Jan Richard Ferris, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 900 E Ganson St, Jackson, MI 49201 Phone: 517-789-6171 Fax: 517-789-6200 | |
The Center For Sight P.c. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3595 Ann Arbor Rd, Jackson, MI 49202 Phone: 517-748-4001 Fax: 517-748-9472 | |
Allison Acker Bissot, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1015 Laurence Ave, Jackson, MI 49202 Phone: 517-787-0364 Fax: 517-787-2272 |